Stroke, not specified as haemorrhage or infarctio
Conditions
Interventions
This study will be a double-blind randomized clinical controlled trial with a parallel intervention assignment. Twenty-eight patients (males and females), who have more than 18 years of age and had a
E02.760.169.063.500.387.875
E02.331.750
L01.224.160.875
Sponsors
Instituto de Física Gleb Wataghin
Instituto de Física Gleb Wataghin
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who suffered a stroke (type 1) more than 6 months prior to participation in the study; patients who have severe hemeparesis as a consequence of the stroke; both female and male patients; patients above 18 years old
Exclusion criteria
Exclusion criteria: Patients who have any type of metal inside their body (pins, pacemakers, metal prostheses, revolver bullets); patients who have any musculoskeletal injury on the affected or unaffected limbs; patients who had previous conditions such as seizures, head trauma, hearing problems, and cochlear implants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We expect to find differences between groups, in which training from group 2 will lead to greater improvements in strength, power, muscle activity and active range of motion of the paretic limbs compared to group 1;We expect to find differences between groups, in which training from group 2 will lead to greater improvements in cortical connectivity and corticospinal excitability, and reductions in pre-synaptic and intracortical inhibition, which will facilitate the neural pathway for greater motor gains of the paretic limbs to occur compared to group 1;We expect to find differences between groups, in which training from group 2 will lead to greater improvements on muscle quality, cross-sectional area, thickness, pennation angle and fascicle length of the paretic muscles compared to group 1 | — |
Secondary
| Measure | Time frame |
|---|---|
| We expect to find differences between groups, in which training from group 2 will lead to greater improvements on the same variables measured on the non-paretic limbs, and on the clinical and funcional performance tests compared to group 1 | — |
Countries
Australia, Brazil
Contacts
Public ContactCássio Víctora Ruas
Universidade Estadual de Campinas
Outcome results
None listed